Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19-Reference-Cited by-同舟云学术

Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19

Published:2022-10-13 Issue:22 Volume:17 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Ghosh Arun K.¹²^ORCID,Mishevich Jennifer L.¹²,Mesecar Andrew¹³⁴,Mitsuya Hiroaki⁵⁶⁷

Affiliation:

1. Department of Chemistry Purdue University West Lafayette IN 47907 USA

2. Department of Medicinal Chemistry and Molecular Pharmacology Purdue University West Lafayette IN 47907 USA

3. Department of Biological Sciences Purdue University West Lafayette IN 47907 USA

4. Department of Biochemistry Purdue University West Lafayette IN 47907 USA

5. Departments of Hematology and Infectious Diseases Kumamoto University School of Medicine Kumamoto 860-8556 Japan

6. Experimental Retrovirology Section HIV and AIDS Malignancy Branch National Cancer Institute Bethesda MD 20892 USA

7. National Center for Global Health and Medicine Research Institute Shinjuku Tokyo 162-8655 Japan

Funder

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200440

Reference159 articles.

1. A new coronavirus associated with human respiratory disease in China

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin

3. V. Zoumpourlis M. Goulielmaki E. Rizos S. Baliou D. Spandidos [Comment] The COVID-19 Pandemic as a Scientific and Social Challenge in the 21st Century.Mol. Med.2020.

4. WHO-convened global study of origins of SARS-CoV-2: China Part.https://www.who.int/publications-detail-redirect/who-convened-global-study-of-origins-of-sars-cov-2-china-part.

5. Coronavirus COVID-19 (2019-nCoV).https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nirmatrelvir (Paxlovid with Ritonavir): A 3‐Chymotrypsin‐like Protease Inhibitor for Treating SARS‐CoV‐2 Infection;Chemistry and Pharmacology of Drug Discovery;2024-08-16

2. New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs;Journal of Medicinal Chemistry;2024-07-05

3. Computational Insights into SARS-CoV-2 Main Protease Mutations and Nirmatrelvir Efficacy: The Effects of P132H and P132H-A173V;Journal of Chemical Information and Modeling;2024-06-24

4. Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review;Bioorganic Chemistry;2024-06

5. Isolation, Virtual Screening, and Evaluation of Hazelnut-Derived Immunoactive Peptides for the Inhibition of SARS-CoV-2 Main Protease;Journal of Agricultural and Food Chemistry;2024-05-13